NAFDAC Drug Evaluation & Research (DER) Directorate Guidelines for Conduct of Clinical Trials during Emergencies
Ministry of Health, National Agency for Food and Drug Administration and Control, Nigeria
This guideline is to provide requirements for the conduct of clinical trials during public health emergencies.
You are viewing a previous version. Click here to view the current version.
Read in full screenProcess Flow
Department of Drug Evaluation and Research ⬤
Office of the Director General NAFDAC ⬤
Office of the Permanent Secretary, Ministry of Health ⬤
Office of the Minister of State for Health ⬤
Office of the minister for health ⬤
Federal Executive Council ⬤
NAFDAC Drug Evaluation & Research (DER) Directorate Guidelines for Conduct of Clinical Trials during Emergencies Current Version
January 2022
This guideline is to provide requirements for the conduct of clinical trials during public health emergencies.
Thank you for requesting an expert analysis
A member of our team will review your request and reply back to the email address on file.